Pharmacokinetics and pharmacodynamics across infusion rates of intravenously administered nipocalimab: results of a phase 1, placebo-controlled study

202415 citationsJournal Articlegold Open Access

Authors

This study supports the use of shortened durations of nipocalimab infusion for future studies.

Good health and well-being

Published in: Frontiers in Neuroscience

Volume 18, pp. 1302714-1302714

Field-Weighted Citation Impact: 5.77